134380.KS
Miwon Chemicals Co., Ltd. [134380.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
134380.KS Stock Summary
In the News
134380.KS Financial details
Company Rating
Buy
Market Cap
141.18B
Income
21.81B
Revenue
232.62B
Book val./share
72152.71
Cash/share
13253.04
Dividend
3000
Dividend %
4.17%
Employees
212
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
7.95
Forward P/E
-
PEG
2.27
P/S
0.64
P/B
1.03
P/C
5.34
P/FCF
10.94
Quick Ratio
1.21
Current Ratio
3.62
Debt / Equity
-0.01
LT Debt / Equity
-0.01
-
-
EPS (TTM)
10.75K
EPS next Y
-
EPS next Q
-
EPS this Y
35.22%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
9.88%
Revenue last 5Y
8.5%
Revenue Q/Q
9.7%
EPS Q/Q
-29.65%
-
-
-
-
SMA20
0.59%
SMA50
0.46%
SMA100
3.49%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
13%
ROC
0.14%
Gross Margin
17%
Oper. Margin
9%
Profit Margin
8%
Payout
33%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
62600.0-74700.0
52W High
-5.22%
52W Low
+13.1%
RSI
57
Rel Volume
1.66
Avg Volume
381
Volume
631
Perf Week
1.14%
Perf Month
0.28%
Perf Quarter
7.93%
Perf Half Y
3.81%
-
-
-
-
Beta
0.33
-
-
Volatility
235.61%, 412.26%
Prev Close
-0.28%
Price
70800
Change
0.43%
134380.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 76.97K | 79.16K | 96.92K | 115.1K | 114.77K | |
| Net income per share | 6.72K | 6.81K | 5.57K | 7.96K | 10.76K | |
| Operating cash flow per share | 10.61K | 10.23K | 4.6K | 13.97K | 17.04K | |
| Free cash flow per share | -2.03K | 2.35K | 1.77K | 5.61K | 11.23K | |
| Cash per share | 2.88K | 4.06K | 1.94K | 5.14K | 13.09K | |
| Book value per share | 50.8K | 55.77K | 58.87K | 64.95K | 71.29K | |
| Tangible book value per share | 50.55K | 55.52K | 58.55K | 64.65K | 70.97K | |
| Share holders equity per share | 50.8K | 55.77K | 58.87K | 64.95K | 71.29K | |
| Interest debt per share | 565.02 | 587.22 | 421.73 | 127.29 | -472.88 | |
| Market cap | 89.66B | 125.3B | 165.45B | 138.93B | 144.91B | |
| Enterprise value | 85.54B | 118.84B | 159.71B | 126.23B | 130.85B | |
| P/E ratio | 6.64 | 9.1 | 14.58 | 8.54 | 6.64 | |
| Price to sales ratio | 0.58 | 0.78 | 0.84 | 0.59 | 0.62 | |
| POCF ratio | 4.2 | 6.05 | 17.64 | 4.87 | 4.19 | |
| PFCF ratio | -21.94 | 26.35 | 45.8 | 12.13 | 6.36 | |
| P/B Ratio | 0.88 | 1.11 | 1.38 | 1.05 | 1 | |
| PTB ratio | 0.88 | 1.11 | 1.38 | 1.05 | 1 | |
| EV to sales | 0.55 | 0.74 | 0.81 | 0.54 | 0.56 | |
| Enterprise value over EBITDA | 3.75 | 4.57 | 6.11 | 3.88 | 3.41 | |
| EV to operating cash flow | 4.01 | 5.74 | 17.03 | 4.42 | 3.79 | |
| EV to free cash flow | -20.93 | 24.99 | 44.21 | 11.02 | 5.75 | |
| Earnings yield | 0.15 | 0.11 | 0.07 | 0.12 | 0.15 | |
| Free cash flow yield | -0.05 | 0.04 | 0.02 | 0.08 | 0.16 | |
| Debt to equity | 0.01 | 0.01 | 0.01 | 0 | -0.01 | |
| Debt to assets | 0.01 | 0.01 | 0.01 | 0 | -0.01 | |
| Net debt to EBITDA | -0.18 | -0.25 | -0.22 | -0.39 | -0.37 | |
| Current ratio | 3.76 | 7.44 | 10.01 | 9.25 | 6.66 | |
| Interest coverage | 1.89K | 4.61K | 61.47K | 68.78K | 1.13M | |
| Income quality | 1.58 | 1.5 | 0.83 | 1.76 | 1.58 | |
| Dividend Yield | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | |
| Payout ratio | 0.14 | 0.28 | 0.43 | 0.3 | 0.27 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -1.19 | -0.77 | -0.61 | -0.6 | -0.34 | |
| Capex to revenue | -0.16 | -0.1 | -0.03 | -0.07 | -0.05 | |
| Capex to depreciation | -4 | -1.58 | -0.49 | -1.48 | -0.88 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 87.63K | 92.42K | 85.9K | 107.85K | 131.39K | |
| ROIC | 0.12 | 0.12 | 0.08 | 0.11 | 0.14 | |
| Return on tangible assets | 0.11 | 0.11 | 0.09 | 0.11 | 0.13 | |
| Graham Net | 5.3K | 8.02K | 9.82K | 13.85K | 20.81K | |
| Working capital | 28.45B | 34.62B | 48.67B | 56.05B | 68.57B | |
| Tangible asset value | 101.63B | 112.38B | 119.3B | 132.09B | 143.84B | |
| Net current asset value | 21.84B | 27.56B | 40.19B | 47.68B | 60.4B | |
| Invested capital | 0.01 | 0.01 | 0.01 | 0 | -0.01 | |
| Average receivables | 20.4B | 20.71B | 24.62B | 30.96B | 34.45B | |
| Average payables | 1.41B | 1.67B | 865.94M | 1.25B | 1.7B | |
| Average inventory | 9.06B | 11.19B | 13.46B | 16.44B | 17.18B | |
| Days sales outstanding | 52.08 | 44.05 | 55.28 | 49.69 | 57.86 | |
| Days payables outstanding | 8.02 | 1.54 | 2.54 | 2.41 | 4 | |
| Days of inventory on hand | 30.11 | 33.3 | 32.3 | 32.7 | 31.6 | |
| Receivables turnover | 7.01 | 8.29 | 6.6 | 7.34 | 6.31 | |
| Payables turnover | 45.5 | 236.56 | 143.79 | 151.28 | 91.19 | |
| Inventory turnover | 12.12 | 10.96 | 11.3 | 11.16 | 11.55 | |
| ROE | 0.13 | 0.12 | 0.09 | 0.12 | 0.15 | |
| Capex per share | -12.64K | -7.88K | -2.83K | -8.37K | -5.81K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 26.44K | 27.74K | 29.42K | 27.36K | 30.19K | |
| Net income per share | 282.97 | 2.5K | 3.22K | 2.95K | 2.08K | |
| Operating cash flow per share | -2.89K | 8.96K | 7.86K | 769.1 | -1.04K | |
| Free cash flow per share | -5.69K | 6.13K | 6.65K | -674.81 | -1.34K | |
| Cash per share | 5.13K | 11.41K | 18.2K | 14.22K | 13.25K | |
| Book value per share | 64.82K | 65.83K | 69.05K | 69.95K | 72.15K | |
| Tangible book value per share | 64.51K | 65.49K | 68.71K | 69.62K | 71.83K | |
| Share holders equity per share | 64.82K | 65.83K | 69.05K | 69.95K | 72.15K | |
| Interest debt per share | 126.92 | 520.46 | 3.13K | 2.65K | -478.61 | |
| Market cap | 139.23B | 129.61B | 133.09B | 129.12B | 143.18B | |
| Enterprise value | 126.53B | 112.32B | 105.58B | 108.01B | 129.11B | |
| P/E ratio | 60.08 | 6.32 | 5.05 | 5.43 | 8.61 | |
| Price to sales ratio | 2.57 | 2.28 | 2.21 | 2.34 | 2.37 | |
| POCF ratio | -23.54 | 7.07 | 8.27 | 83.34 | -69.02 | |
| PFCF ratio | -11.94 | 10.33 | 9.77 | -94.99 | -53.45 | |
| P/B Ratio | 1.05 | 0.96 | 0.94 | 0.92 | 0.99 | |
| PTB ratio | 1.05 | 0.96 | 0.94 | 0.92 | 0.99 | |
| EV to sales | 2.34 | 1.98 | 1.75 | 1.96 | 2.14 | |
| Enterprise value over EBITDA | 36.83 | 12.08 | 9.67 | 10.57 | 14.74 | |
| EV to operating cash flow | -21.39 | 6.12 | 6.56 | 69.71 | -62.24 | |
| EV to free cash flow | -10.85 | 8.95 | 7.75 | -79.46 | -48.2 | |
| Earnings yield | 0 | 0.04 | 0.05 | 0.05 | 0.03 | |
| Free cash flow yield | -0.08 | 0.1 | 0.1 | -0.01 | -0.02 | |
| Debt to equity | 0 | 0.01 | 0.05 | 0.04 | -0.01 | |
| Debt to assets | 0 | 0.01 | 0.04 | 0.03 | -0.01 | |
| Net debt to EBITDA | -3.7 | -1.86 | -2.52 | -2.07 | -1.61 | |
| Current ratio | 9.25 | 3.16 | 3.41 | 3.62 | 6.66 | |
| Interest coverage | 6.57K | 241.14K | 0 | 0 | 262.82M | |
| Income quality | -10.21 | 3.58 | 2.44 | 0.26 | -0.5 | |
| Dividend Yield | 0 | 0.02 | 0 | 0.02 | 0 | |
| Payout ratio | 0 | 0.58 | 0 | 0.5 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.97 | -0.32 | -0.15 | -1.88 | 0.29 | |
| Capex to revenue | -0.11 | -0.1 | -0.04 | -0.05 | -0.01 | |
| Capex to depreciation | -1.94 | -1.82 | -0.78 | -0.82 | -0.17 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 20.31K | 60.91K | 70.69K | 68.14K | 58.05K | |
| ROIC | 0.01 | 0.03 | 0.04 | 0.04 | 0.03 | |
| Return on tangible assets | 0 | 0.03 | 0.04 | 0.03 | 0.03 | |
| Graham Net | 13.82K | 13.89K | 17.95K | 17.42K | 21.06K | |
| Working capital | 56.05B | 54.96B | 60.67B | 61.86B | 68.57B | |
| Tangible asset value | 132.09B | 134.09B | 140.67B | 140.25B | 143.84B | |
| Net current asset value | 47.68B | 47.05B | 52.86B | 53.99B | 60.4B | |
| Invested capital | 0 | 0.01 | 0.05 | 0.04 | -0.01 | |
| Average receivables | 37.6B | 35.88B | 36.95B | 36.64B | 38B | |
| Average payables | 9.69B | 7.5B | 13.77B | 13.71B | 7.83B | |
| Average inventory | 18.43B | 17.6B | 15.58B | 15.48B | 16.83B | |
| Days sales outstanding | 53.23 | 62.98 | 51.03 | 63.88 | 54.89 | |
| Days payables outstanding | 2.55 | 26.03 | 25.67 | 27.46 | 3.76 | |
| Days of inventory on hand | 34.53 | 33 | 25.6 | 34.7 | 29.7 | |
| Receivables turnover | 1.69 | 1.43 | 1.76 | 1.41 | 1.64 | |
| Payables turnover | 35.33 | 3.46 | 3.51 | 3.28 | 23.93 | |
| Inventory turnover | 2.61 | 2.73 | 3.52 | 2.59 | 3.03 | |
| ROE | 0 | 0.04 | 0.05 | 0.04 | 0.03 | |
| Capex per share | -2.81K | -2.83K | -1.21K | -1.44K | -301.79 |
134380.KS Frequently Asked Questions
What is Miwon Chemicals Co., Ltd. stock symbol ?
Miwon Chemicals Co., Ltd. is a KR stock and trading under the symbol 134380.KS
What is Miwon Chemicals Co., Ltd. stock quote today ?
Miwon Chemicals Co., Ltd. stock price is $70800 today.
Is Miwon Chemicals Co., Ltd. stock public?
Yes, Miwon Chemicals Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 381
- Market Capitalization 141.18B
- Employee 212
- CEO Eric G. Chong
- Headquarters Anyang-Si,KR
- IPO Date 2011-02-15
-
Website
https://www.miwonchemicals.com 
Miwon Chemicals Co., Ltd. develops, manufactures, and sells performance chemicals for use in the rubber, detergent, and personal care industries worldwide. Its products include sulfurs; sulfuric acids; sulphonic acid; alkyl sulfates; and rubber chemicals, such as prevalcanization inhibitors and tire bonding agents. The company was founded in 1959 and is headquartered in Anyang, South Korea.
